The Cigna (CI) Fundamental Analysis: Revenue, Earnings & Valuation

7.77 / 10

Outperform

Fundamental metrics rate CI as Outperform with a 7.8/10 rating. Strengths include strong cash‑to‑market, high PB‑ROE, robust EPS growth, and solid profit increases. Weak points are modest revenue‑to‑market value and negative operating cash‑flow growth. Overall, fundamentals are deemed superior.

Analysis Checks(6/10)

Revenue-MV

Value2.58

Score1/3

Weight3.56%

1M Return1.38%

Net cash flow from operating activities per share (YoY growth rate %)

Value-3.72

Score0/3

Weight-6.49%

1M Return-2.82%

PB-ROE

Value-0.59

Score3/3

Weight21.38%

1M Return7.08%

Basic earnings per share (YoY growth rate %)

Value82.29

Score3/3

Weight18.12%

1M Return5.83%

Total profit (YoY growth rate %)

Value47.68

Score3/3

Weight15.99%

1M Return5.02%

Cash-UP

Value0.69

Score1/3

Weight-0.72%

1M Return-0.29%

Diluted earnings per share (YoY growth rate %)

Value83.00

Score3/3

Weight18.76%

1M Return6.07%

Asset-MV

Value-0.55

Score0/3

Weight-0.89%

1M Return-0.40%

Net profit attributable to parent company shareholders (YoY growth rate %)

Value73.47

Score3/3

Weight12.93%

1M Return4.20%

Cash-MV

Value1.58

Score3/3

Weight17.38%

1M Return5.04%

Is CI undervalued or overvalued?

CI scores 7.77/10 on fundamentals and holds a Discounted valuation at present. Backed by its 14.33% ROE, 2.29% net margin, 11.86 P/E ratio, 1.69 P/B ratio, and 82.29% earnings growth, these metrics solidify its Outperform investment rating.